Siste måned
30 dager
-17 778
NETTO POSISJON (NOK)
Handler
4
Kjøp
15 845
Salg
33 623
6 måneder
180 dager
+568 952
NETTO POSISJON (NOK)
Handler
30
Kjøp
602 575
Salg
33 623
Historikk
ℹ️ Om innsidehandel
Primærinnsidere er personer med ledelsesansvar og deres nærstående. Meldeplikt inntrer når transaksjoner når EUR 5 000 i et kalenderår.
Meldefrist: umiddelbart, senest tre virkedager. Handelsforbud 30 dager før pliktig finansiell rapportering.
Transaksjoner
Mer info 👉
| Dato | Innsider | Antall | Pris | Verdi |
|---|---|---|---|---|
| 06.05.2026 |
Thomas Falck
Board member
|
10 376 | 0.60 | 6 226 |
| 06.05.2026 |
Thomas Falck
Board member
|
4 041 | 8.32 | 33 623 |
| 06.05.2026 |
Diane Mary Mellet
Board member
|
2 020 | 0.60 | 1 212 |
| 06.05.2026 |
Damian Marron
Chairman
|
14 012 | 0.60 | 8 407 |
| 30.01.2026 |
Damian Marron
Chairman
|
128 595 | 1.00 | 128 595 |
| 13.02.2026 |
Ola Melin
Chief Operation Officer
|
500 000 | - | - |
| 13.02.2026 |
Lubor Gaal
CFO
|
750 000 | - | - |
| 13.02.2026 |
Erik Digman Wiklund
CEO
|
1 200 000 | - | - |
| 13.02.2026 |
Victor Levitsky
Chief Scientific Officer
|
500 000 | - | - |
| 13.02.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
750 000 | - | - |
| 28.01.2026 |
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
|
65 164 | 1.00 | 65 164 |
| 27.01.2026 |
Thomas Falck
Board member
via Sølen AS
|
65 164 | 1.00 | 65 164 |
| 26.01.2026 |
Victor Levitsky
Chief Scientific Officer
|
32 698 | 1.00 | 32 698 |
| 21.01.2026 |
Robert Forbes Burns
Deputy Board member
|
11 542 | 1.00 | 11 542 |
| 21.01.2026 |
Ola Melin
Chief Operation Officer
|
33 161 | 1.00 | 33 161 |
| 21.01.2026 |
Diane Mary Mellet
Board member
|
60 000 | 1.00 | 60 000 |
| 21.01.2026 |
Damian Marron
Chairman
|
58 918 | 1.00 | 58 918 |
| 19.01.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
32 582 | 1.00 | 32 582 |
| 16.01.2026 |
Erik Digman Wiklund
CEO
via Digman AS
|
1 160 | 1.00 | 1 160 |
| 16.01.2026 |
Erik Digman Wiklund
CEO
|
97 746 | 1.00 | 97 746 |
| 15.01.2026 |
Diane Mary Mellet
Board member
|
67 405 | - | - |
| 15.01.2026 |
Thomas Falck
Board member
via Sølen AS
|
65 164 | - | - |
| 15.01.2026 |
Victor Levitsky
Chief Scientific Officer
|
32 698 | - | - |
| 15.01.2026 |
Lubor Gaal
CFO
via Biopharma Drug Licensing Group, SL
|
65 164 | - | - |
| 15.01.2026 |
Thomas Birkballe Hansen
Chief Technology Officer
|
32 582 | - | - |
| 15.01.2026 |
Ola Melin
Chief Operation Officer
|
33 162 | - | - |
| 15.01.2026 |
Erik Digman Wiklund
CEO
|
97 746 | - | - |
| 15.01.2026 |
Erik Digman Wiklund
CEO
via Digman AS
|
1 160 | - | - |
| 15.01.2026 |
Damian Marron
Chairman
|
58 918 | - | - |
| 15.01.2026 |
Robert Forbes Burns
Deputy Board member
|
30 792 | - | - |
| Vis færre ▲ | ||||
Vis alle 30 transaksjoner
▼
Pressemeldinger
| Dato | Melding |
|---|---|
| 07.05.2026 |
Circio Holding ASA: Mandatory notification of trade by primary insiders pertaining to settlement of RSUs
Oslo, 7 May 2026: Reference is made to Circio Holding ASA's (OSE: CRNA) (the
"Company") stock exchange announcement published on 6 May 2026, regarding...
|
| 26.02.2026 |
Correction - Mandatory notification of trade by primary insider related to the rights issue
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY,
IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA,
...
|
| 14.02.2026 |
Circio announces allocation of stock options to key employees
Oslo, Norway, 14 February 2026 -- Circio Holding ASA (OSE: CRNA), a
biotechnology company developing novel circular RNA expression technology for
gene...
|
| 29.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 29 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 28.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 28 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 21.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 21 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 16.01.2026 |
Circio Holding ASA Exercise of subscription rights in the rights issue by primary insiders
Oslo, 16 January 2026: Reference is made to the stock exchange announcements
by Circio Holding ASA (the "Company") on 15 January 2026, regarding the
c...
|
| 15.01.2026 |
Circio Holding ASA Receipt of subscription rights in the rights issue by primary insiders and their close associates
Oslo, 15 January 2026: Reference is made to the stock exchange announcement by
Circio Holding ASA (the "Company") earlier today, 15 January 2026, rega...
|
| Vis færre ▲ | |
Vis alle 8 meldinger
▼